Kim Frisch
- Organic Chemistry top 10%
- Oncology
- Epidemiology
- Radiology, Nuclear Medicine and Imaging top 10%
- Hepatology top 10%
- Co-authors
- Karl Anker JørgensenMichael SørensenSusanne KeidingSteen SaabyAitor LandaOle Lajord MunkPeter OttChristian Jacobsen
- Topics
- Drug Transport and Resistance Mechanisms (11 papers)Pediatric Hepatobiliary Diseases and Treatments (8 papers)Liver Disease Diagnosis and Treatment (6 papers)
- Cited by
- HepatologyOrganic ChemistryOncology
- Partner nations
- DenmarkUnited StatesAustralia
In The Last Decade
Kim Frisch
32 papers receiving 687 citations
Peers
Comparison fields: 5 of 75
- Organic Chemistry 281
- Oncology 165
- Epidemiology 122
- Radiology, Nuclear Medicine and Imaging 118
- Hepatology 106
Countries citing papers authored by Kim Frisch
This map shows the geographic impact of Kim Frisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Frisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Frisch more than expected).
Fields of papers citing papers by Kim Frisch
This network shows the impact of papers produced by Kim Frisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Frisch. The network helps show where Kim Frisch may publish in the future.
Co-authorship network of co-authors of Kim Frisch
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Frisch. A scholar is included among the top collaborators of Kim Frisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Frisch. Kim Frisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 21 | |
| 5 | 24 | |
| 6 | 62 | |
| 7 | 8 | |
| 8 | 6 | |
| 9 | 7 | |
| 10 | 40 | |
| 11 | 22 | |
| 12 | 18 | |
| 13 | 3 | |
| 14 | 24 | |
| 15 | 30 | |
| 16 | 19 | |
| 17 | 31 | |
| 18 | 66 | |
| 19 | 112 | |
| 20 | 3 |
About Kim Frisch
Kim Frisch is a scholar working on Clinical Biochemistry, Oncology and Hepatology, having authored 32 papers that have together received 692 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Hepatology (106 citations), Organic Chemistry (281 citations) and Oncology (165 citations). Kim Frisch has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Karl Anker Jørgensen, Michael Sørensen, Susanne Keiding, Steen Saaby, Aitor Landa, Ole Lajord Munk, Peter Ott, Christian Jacobsen, José Alemán and Mark Bell. Their work appears in journals such as Angewandte Chemie International Edition, Analytical Chemistry and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.